Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Loan payable under credit agreement to beneficial shareholder, net of unamortized issuance costs (in Dollars)	$ 70,780	$ 352,252
Promissory notes to related parties, net of unamortized issuance costs (in Dollars)	649,953	0
Promissory note related to acquisition, net of discount (in Dollars)		1,165,027
Loan payable under Basepoint credit agreement, net of unamortized issuance costs (in Dollars)	$ 92,963
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	21,752,304	21,750,804
Common stock, shares outstanding	21,752,304	21,750,804
Treasury shares	164,029
Series 1 Convertible Preferred Stock
Convertible preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized	250,000	250,000
Convertible preferred stock, shares issued	170,332	170,332
Convertible preferred stock, shares outstanding	170,332	170,332
Convertible Preferred Stock, stated value (in Dollars)	$ 5	$ 5
Series 2 Convertible Preferred Stock
Convertible preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized	25,000	25,000
Convertible preferred stock, shares issued	21,952	21,952
Convertible preferred stock, shares outstanding	21,952	21,952
Convertible Preferred Stock, stated value (in Dollars)	$ 1,000	$ 1,000